Bill114th CongressFiled Jun 23, 2016Health
H.R. 5573
PRICED Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jun 23, 2016)
Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act
This bill amends the Public Health Service Act to allow biosimilars to be marketed seven years after the reference brand name biological product is licensed. Currently, brand name biological products are provided a 12-year marketing exclusivity period.
This shortened marketing exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.What just happenedJun 23, 2016
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Schakowsky, Janice D. [D-IL-9](D-IL)Sponsor
8 cosponsors8 D
8cosponsors1committees3actions1related bills3subjects
- Introduced in HouseJun 23, 2016
- Jun 23, 2016IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jun 23, 2016IntroReferralIntro-H
Introduced in House
- Jun 23, 2016IntroReferral1000
Introduced in House